Top pharma cos build around $3.5 billion war chest for inorganic growth 0 24.05.2024 13:09 Thehindubusinessline.com The cash surplus with pharma companies has been consistently rising from FY21 onwards to reach around ₹28,100 crore, according to data by Ambit Capital Research Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
